Estradiol rates of change in relation to the final menstrual period in a population-based cohort of women
- PMID: 18647803
- PMCID: PMC2579642
- DOI: 10.1210/jc.2008-1056
Estradiol rates of change in relation to the final menstrual period in a population-based cohort of women
Abstract
Context/objective: The aim was to characterize rates of change in serum estradiol (E2) levels across the menopausal transition and into early postmenopause.
Setting/participants: We studied the Michigan Bone Health and Metabolism Study cohort of 629 women with median age of 38 yr (interquartile range, 7) at the 1992-1993 baseline with annual assessment of E2 levels over the subsequent 15-yr period. DESIGN/MAIN OUTCOME MEASURES: The purpose was to describe patterns of acceleration/deceleration in (log)E2 rates of change before and after the final menstrual period (FMP) using nonparametric and piecewise regression modeling.
Results: Between -10 to -2 yr to the FMP, mean fitted serum E2 population values were relatively stable. The 95% confidence bands around the slight increase in E2 rate of change 5 yr prior to the FMP included the value of no change. The fitted population mean E2 value declined 67% from 64.5 pg/ml (se = 3.6) to 21 pg/ml (se = 1.2) in the 4 yr between -2 < FMP < +2. A second significant mean E2 rate of change was identified from 6-8 yr after FMP. Fitted population mean E2 values declined 18% from 18.1 pg/ml (se = 1.3) at FMP = 6 to 14.8 pg/ml (se = 1.3) at FMP = 8. In nonobese women, the mean E2 percent decline was 42% from FMP = 6 to FMP = 8, whereas in obese women, the mean E2 percent decline over this time was 31%.
Conclusions: Population mean serum E2 levels were sustained until approximately 2 yr prior to the FMP. In the ensuing 4-yr period, E2 levels declined 67%. A secondary E2 decline, commencing about 6 yr after the FMP, was observed in nonobese but not obese women.
Figures
Similar articles
-
Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period.J Clin Endocrinol Metab. 2011 Mar;96(3):746-54. doi: 10.1210/jc.2010-1746. Epub 2010 Dec 15. J Clin Endocrinol Metab. 2011. PMID: 21159842 Free PMC article.
-
A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition.J Clin Endocrinol Metab. 2000 Aug;85(8):2832-8. doi: 10.1210/jcem.85.8.6740. J Clin Endocrinol Metab. 2000. PMID: 10946891
-
Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women.J Clin Endocrinol Metab. 1999 Nov;84(11):4025-30. doi: 10.1210/jcem.84.11.6158. J Clin Endocrinol Metab. 1999. PMID: 10566644
-
Follicle stimulating hormone and its rate of change in defining menopause transition stages.J Clin Endocrinol Metab. 2008 Oct;93(10):3958-64. doi: 10.1210/jc.2008-0482. Epub 2008 Jul 22. J Clin Endocrinol Metab. 2008. PMID: 18647816 Free PMC article.
-
The menopausal transition--endocrinology.J Sex Med. 2008 Oct;5(10):2266-73. doi: 10.1111/j.1743-6109.2008.00921.x. Epub 2008 Jul 1. J Sex Med. 2008. PMID: 18624962 Review.
Cited by
-
Zoledronic acid in the treatment of early-stage breast cancer: is there a final verdict?Curr Oncol Rep. 2012 Feb;14(1):35-43. doi: 10.1007/s11912-011-0209-5. Curr Oncol Rep. 2012. PMID: 22113793 Review.
-
The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis.Ann Oncol. 2012 Nov;23(11):2782-2790. doi: 10.1093/annonc/mds169. Epub 2012 Jun 22. Ann Oncol. 2012. PMID: 22730099 Free PMC article. Review.
-
Associations between polygenic risk score for age at menarche and menopause, reproductive timing, and serum hormone levels in multiple race/ethnic groups.Menopause. 2021 Apr 19;28(7):819-828. doi: 10.1097/GME.0000000000001775. Menopause. 2021. PMID: 33878091 Free PMC article.
-
Hormone changes associated with the menopausal transition.Minerva Ginecol. 2009 Dec;61(6):483-9. Minerva Ginecol. 2009. PMID: 19942836 Free PMC article. Review.
-
Aging attenuates the pituitary response to gonadotropin-releasing hormone.J Clin Endocrinol Metab. 2009 Sep;94(9):3259-64. doi: 10.1210/jc.2009-0526. Epub 2009 Jun 23. J Clin Endocrinol Metab. 2009. PMID: 19549740 Free PMC article.
References
-
- Sherman BM, West JH, Korenman SG 1976 The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 42:629–636 - PubMed
-
- Lee SJ, Lenton EA, Sexton L, Cooke ID 1988 The effect of age on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles. Hum Reprod 3:851–855 - PubMed
-
- Metcalf MG, Donald RA, Livesey JH 1981 Pituitary-ovarian function in normal women during the menopausal transition. Clin Endocrinol (Oxf) 14:245–255 - PubMed
-
- Burger HG, Dudley EC, Hopper JL, Shelley JM, Green A, Smith A, Dennerstein L, Morse C 1995 The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab 80:3537–3545 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
